Prostate cancer is cancer that starts in the prostate gland. The prostate gland is found at the base of the bladder and is about the size of a walnut. 

It is the most common cancer in men in the UK. Some trans women and non-binary people (who are born male) can also get prostate cancer. 

What is prostate cancer?

Prostate cancer is cancer of the prostate gland. Find out about who gets prostate cancer and how common it is. 

Symptoms of prostate cancer

Prostate cancer doesn't usually cause any symptoms in the early stages. 

Tests for prostate cancer

You have a number of tests to check for prostate cancer. These may include a digital rectal examination, a PSA blood test, scans and a biopsy. 

Getting diagnosed with prostate cancer

You usually start by seeing your GP. They ask about your symptoms and examine you. Your GP then decides whether to refer you to a specialist.

Survival for prostate cancer

Survival for prostate cancer is generally good, particularly if you are diagnosed early. 

Treatment for prostate cancer

Your treatment depends on a number of factors including how big the cancer is, whether it has spread anywhere else in your body and how well you are.

Stages, types and grades of prostate cancer

Get information about how doctors stage prostate cancer, the Gleason score and the Cambridge Prognostic Group (CPG).

Metastatic prostate cancer

Metastatic prostate cancer means that a cancer that began in the prostate has spread to another part of the body.

Research and clinical trials for prostate cancer

Find out about the latest UK research, clinical trials and how you can take part.

Living with prostate cancer

Get practical and emotional support to help you cope with a diagnosis of prostate cancer, and life during and after treatment.

Risks and causes of prostate cancer

Your risk of developing prostate cancer depends on many things including age and ethnicity.

Last reviewed: 
15 Mar 2022
Next review due: 
15 Mar 2025

Page Credits

This section has been written, reviewed and updated by Cancer Research UK’s Patient Information Web Team. Thanks to the expert medical professionals and people affected by cancer who have helped to review this information.

  • Professor Vincent J Gnanapragasam (Professor of Urology and Honorary Consultant Urologist)

  • Dr Julia Murray (Consultant Clinical Oncologist) 

  • Jane Brocksom (Lead nurse for urology)